EPZM
Epizyme, Inc
EPZM
EPZM
Delisted
EPZM was delisted on the 11th of August, 2022.
109 hedge funds and large institutions have $1.06B invested in Epizyme, Inc in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+8
Holders Change %
+7.92%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
23
Increased
38
Reduced
30
Closed
14
Calls
$1.17M
Puts
$947K
Net Calls
+$227K
Net Calls Change
-$881K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.15M |
| 3 |
Jennison Associates
New York
|
+$4.84M |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.28M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$2.83M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$7.09M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.51M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.66M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.92M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.61M |
